Pharmacoeconomic analyses appear to account for differences in recommendations made regarding public payment when national bodies consider the same drugs for the same indication.
Joel Lexchin, MD
Advertisement
Articles by Joel Lexchin, MD
Advertisement
Latest Updated Articles
- Medicine Reimbursement Recommendations in Canada, Australia, and Scotland
September 15th 2008
Advertisement
Advertisement
Trending on AJMC
1
Trump Childhood Vaccine Order: What It Means for Parents and Payers
2
Senate Unveils Sweeping Bill to Reform 340B Drug Program
3
Occupational Triggers Fuel Half of CHE Cases, Spanish Study Finds
4
Access, Coverage, and Final Reflections on Managing Alzheimer's Disease Agitation
5